Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
Arezoo Beig Parikhani, Masoume Bazaz, Hadi Bamehr, et al.
Current Microbiology (2021) Vol. 78, Iss. 4, pp. 1099-1114
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Detection and discrimination of SARS-CoV-2 spike protein-derived peptides using THz metamaterials
Soo Hyun Lee, Yeon Kyung Lee, Sang‐Hun Lee, et al.
Biosensors and Bioelectronics (2022) Vol. 202, pp. 113981-113981
Open Access | Times Cited: 43
Emergence of SARS-CoV-2 New Variants and Their Clinical Significance
Hitesh Singh, Nisha Dahiya, Mahima Yadav, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 33
Natural products as potential lead compounds to develop new antiviral drugs over the past decade
Jing-Han Zhao, Yuewei Wang, Jin Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115726-115726
Closed Access | Times Cited: 20
Adverse reactions to COVID‐19 vaccines: A practical approach
Krzysztof Rutkowski, Rita Mirakian, Stephen J. Till, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 6, pp. 770-777
Open Access | Times Cited: 41
S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants
Ram Kumar, Nitin Khandelwal, Yogesh Chander, et al.
Antiviral Research (2021) Vol. 197, pp. 105232-105232
Open Access | Times Cited: 33
Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections
Nour Mammari, Ysaline Krier, Quentin Albert, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 774-774
Open Access | Times Cited: 30
The Development of Aptamer-Based Gold Nanoparticle Lateral Flow Test Strips for the Detection of SARS-CoV-2 S Proteins on the Surface of Cold-Chain Food Packaging
Xiaotong Li, Jiachen Wang, Ge Yang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1776-1776
Open Access | Times Cited: 3
The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries
Mitra Salehi, Shahin Amiri, Dariush Ilghari, et al.
Indian Journal of Clinical Biochemistry (2022) Vol. 38, Iss. 2, pp. 159-171
Open Access | Times Cited: 15
3D interior hotspots embedded with viral lysates for rapid and label-free identification of infectious diseases
Soo Hyun Lee, Iris Baffour Ansah, Won‐Chul Lee, et al.
Chemical Engineering Journal (2022) Vol. 454, pp. 140066-140066
Open Access | Times Cited: 15
Development of Aptamer-Based Gold Nanoparticle Lateral Flow Test Strips for Detection of SARS-CoV-2 S Protein on the Surface of Cold Chain Food Packaging
Xiaotong Li, Jiachen Wang, Xiaona Fang, et al.
(2024)
Open Access | Times Cited: 3
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
Raluca Dumache, Alexandra Enache, Ioana Macașoi, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 516-516
Open Access | Times Cited: 14
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Andrea Carolina Machado-Sulbarán, et al.
Immunology Letters (2022) Vol. 251-252, pp. 20-28
Open Access | Times Cited: 12
Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells
Zening Yang, Jing Li, Jiali Li, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2042-2042
Open Access | Times Cited: 8
Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran
Mona Sadat Larijani, Alireza Biglari, Rahim Sorouri, et al.
Deleted Journal (2024) Vol. 28, Iss. 1, pp. 1-7
Open Access | Times Cited: 1
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety
Eric Murillo-Rodrı́guez, Jocelyne Alcaraz-Silva, Daniel L. Feingold, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 3, pp. 417-430
Closed Access | Times Cited: 7
Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives
Blake M. Shellenberger, Olivia N. Basile, Joel Cassel, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 102, pp. 129679-129679
Closed Access | Times Cited: 1
Empfehlungen zu SARS-CoV-2/COVID-19 in Schwangerschaft, Geburt und Wochenbett – Update November 2021 (Langfassung)
Janine Zöllkau, Carsten Hagenbeck, Kurt Hecher, et al.
Zeitschrift für Geburtshilfe und Neonatologie (2021) Vol. 226, Iss. 01, pp. e1-e35
Closed Access | Times Cited: 9
SARS-CoV-2 in Egypt: epidemiology, clinical characterization and bioinformatics analysis
Badriyah S. Alotaibi, Thanaa A. El‐Masry, Mohamed G. Seadawy, et al.
Heliyon (2022) Vol. 8, Iss. 2, pp. e08864-e08864
Open Access | Times Cited: 6
Experimental evidence to the untapped potential of Ayurvedic herb, Ashwagandha: Bench-to-Bedside
Renu Wadhwa, Sunil C. Kaul
International Journal of Ayurveda Research (2023) Vol. 4, Iss. 1, pp. 15-27
Open Access | Times Cited: 3
Oral SARS‐CoV‐2 reduction by local treatment: A plasma technology application?
Thomas von Woedtke, Gülşah Gabriel, Ulrich E. Schaible, et al.
Plasma Processes and Polymers (2022) Vol. 20, Iss. 3
Open Access | Times Cited: 5
Respuesta inmunitaria innata pulmonar en la infección por Sars-Cov-2
Emanuel Bottino, A.A. Ponce
Revista de la Facultad de Ciencias Médicas de Córdoba (2022) Vol. 79, Iss. 1, pp. 33-42
Open Access | Times Cited: 3
Computational Analysis of Short Linear Motifs in the Spike Protein of SARS-CoV-2 Variants Provides Possible Clues into the Immune Hijack and Evasion Mechanisms of Omicron Variant
Anjana Soorajkumar, Ebrahim Alakraf, Mohammed Uddin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8822-8822
Open Access | Times Cited: 3
Short-term Safety of Covaxin, Sinopharm, Sputnik V, and AstraZeneca COVID-19 Vaccines Among Iranian Healthcare Workers: A Cross-Sectional Study
Reza Sinaei, Mohammad Javad Najafzadeh, Somayeh Ghafari, et al.
Archives of Clinical Infectious Diseases (2024) Vol. 19, Iss. 1
Open Access
The risk of adverse cardiovascular complications following covid-19 vaccination
Md Sadique Hussain, Md Taufique Alam, Rahul Sharma
Pharmacy & Pharmacology International Journal (2023) Vol. 11, Iss. 1, pp. 10-13
Open Access | Times Cited: 1
Association of maternal infection of SARS-CoV-2 and neonatal susceptibility: A retrospective cohort study
Xiaodan Zhu, Yanjie Peng, Ying Chen, et al.
Vaccine X (2024) Vol. 20, pp. 100536-100536
Open Access
Page 1 - Next Page

Scroll to top